Myeloproliferative neoplasms trials in Malaysia

4 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)

  Where

  George Town, Johor Bahru, Kota Kinabalu, Kuala Selangor, Kuching

  Age

  18 years and over

  People

  460 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT07357727 · EU 2025-523555-66-00
• Phase 4Taking people
  Asciminib Roll-over Study

  Where

  George Town, Johor Bahru, Kuala Selangor

  Age

  7 years to 100 years

  People

  347 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT04877522 · EU 2023-507557-16-00
• Phase 3Taking people
  A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

  Where

  Ampang, George Town, Kota Kinabalu, Kuala Lumpur

  Age

  18 years and over

  People

  324 worldwide

  Run by

  Takeda

  See details and how to joinNCT07623161 · EU 2026-525660-17-00
• Phase 3Taking people
  A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials

  Where

  Alor Star, Ipoh, Johor Bahru, Kota Kinabalu, Kuala Lumpur, Kuching

  Age

  18 years and over

  People

  665 worldwide

  Run by

  Celgene

  See details and how to joinNCT04064060